Vimarsana
Biggest News Aggregation in the World

Evommune Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evommune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evommune Inc Today - Breaking & Trending Today

Evommune Announces Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 antagonist EVO756 in Japan - Vimarsana News

Evommune Announces Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 antagonist EVO756 in Japan

/PRNewswire/ -- Evommune, Inc., a biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced...

Roundups: Recent Digital Health Hires & Board Appointments - Vimarsana News

Roundups: Recent Digital Health Hires & Board Appointments

Roundup summary of digital health hires and executive board appointments from GHX, QuantHealth, Hopper, Icario, Carenet Health, others

Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune - Vimarsana News

Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune

Arix Co-leads $50 Million Series B Financing for New Portfolio Company EvommuneLONDON, 27 April 2023: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a transatlantic venture capital company focused on investing in breakthrough biotechnology companies, announces that the Series B fi...

Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune - Vimarsana News

Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune

Arix Bioscience PLC (ARIX) Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune 27-Apr-2023 / 07:00 GMT/BST ...

Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases - Vimarsana News

Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases

/PRNewswire/ -- Evommune, Inc., a clinical-stage biotechnology company discovering and developing new ways to treat inflammatory diseases, today announced the...